3 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow Prokidney: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007) Renal Autologous Cell Therapy (REACT) - Chronic Kidney Diseases, Type 1 Diabetes Mellitus | Phase 2 | Completed | Prokidney | 53 | 2021-07-27 | 2026-03-13 |
| A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease Renal Autologous Cell Therapy (REACT) - Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 2 | Completed | Prokidney | 10 | 2018-04-25 | 2025-03-24 |
| A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Renal Autologous Cell Therapy (REACT), Renal Biopsy - Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 2 | Completed | Prokidney | 83 | 2016-09-01 | 2025-08-24 |
| Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) Neo-Kidney Augment - Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | Terminated | Prokidney | 1 | 2016-07-01 | 2021-04-23 |
Diabetes Mellitus, Type 2 (4) · Renal Insufficiency, Chronic (4) · Diabetes Mellitus, Type 1 (1)
United States (4)
Ashley Johns (1) · Ashley Johns, MSHS (1) · Brian Johnston (1) · Catherine Taylor (1)